Yongpeng Sun-Tastaufen
BANNED
![](/styles/default/xenforo/ranks/General.jpg)
- Joined
- Oct 15, 2017
- Messages
- 28,401
- Reaction score
- -82
- Country
- Location
![www.reuters.com](/proxy.php?image=https%3A%2F%2Fwww.reuters.com%2Fresizer%2Fi_TINnKfSXks5UAh6xFn6DaAP3A%3D%2F1200x628%2Fsmart%2Ffilters%3Aquality%2880%29%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FALWDSCPFHVL4BPSTQLDFSG5ZDM.jpg&hash=09a84c29af3c95640f6f04af007382dd&return_error=1)
CanSinoBIO's inhalation COVID-19 shot in mid-stage trial, says CEO
An inhalation version of CanSino Biologics' (6185.HK), COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
BEIJING, June 2 (Reuters) - An inhalation version of CanSino Biologics' (6185.HK), COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
Yu made the comment at a panel of the Global Health Forum of the Boao Forum for Asia.
Reporting by Roxanne Liu and Ryan Woo Editing by David Goodman
Our Standards: The Thomson Reuters Trust Principles.
So it's like this yeah?
@nahtanbob @Hamartia Antidote @Oldman1 @denel @aziqbal @White and Green with M/S @rambro @FuturePAF @Han Patriot @Beast @Suika @vostok @mike2000 is back
Last edited: